Summary
BACKGROUND: The epidemic of obesity assumes vast proportions with approximately estimated 2.3 billion overweight adults and more than 700 millions defined as obese according to the World Health Organization in 2015. The close relation between obesity and its co-morbidities such as hypertension, insulin resistance and diabetes mellitus type 2 are well documented. Laparoscopic sleeve gastrectomy (LSG) was initially described as a first-step procedure followed by either biliopancreatic diversion with duodenal switch (BPD-DS) or Roux-en-Y gastric bypass (RYGBP) in super-super obese patients (i.e. BMI>60 kg/m2) or in high-risk patients. On the other hand the role of LSG as a single procedure is yet unclear and controversial. METHODS: We report about 83 patients enrolled for LSG as single bariatric procedure and a follow-up period of 12 months or more. Follow-up was performed continuously every 3 months and data regarding weight loss, GERD and subjective well-being as well as blood samples were collected. Mean preoperative BMI was 49 kg/m2 (range 38–74). RESULTS: Within 12 months patients reached a mean EWL of 63% (31–90%). 22 patients, who suffered preoperatively from diabetes mellitus type 2 showed amelioriation of the disease. Hba1c levels dropped from 6.2% to 5.3%. In 2 (2.4%) cases patients had to be reoperated because of bleeding. 1 (1.2%) patient underwent reoperation because of leakage of the staple line. 13 (15.7%) patients complained about GERD symptoms. Some patients showed occasional symptoms, others could be treated conservatively. CONCLUSIONS: Single-step LSG is very well accepted by patients and seems to be efficient regarding weight loss, although large studies concerning long-term results are still rare. In our patients there are some cases of GERD, which seem to ameliorate in the course of time, but objective data are still lacking and further evaluation is necessary.
Similar content being viewed by others
References
World Health Organization fact sheet No 311, September 2006
Poglitsch M, Kefurt R, Mittlböck M, et al. Prevalence of obesity and overweight in male 18-year-olds in Austria from 2006–2010: an update. Eur Surg 2011;3:181–6
Freedman DM, Ron E, Ballard-Barbash R, et al. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) 2006;30:822–9
van Dam RM, Willett WC, Manson JE, et al. The relationship between overweight in adolescence and premature death in women. Ann Intern Med 2006;145:91–7
Price GM, Uauy R, Breeze E, et al. Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr 2006;84:449–60
Jee SH, Sull JW, Park J, et al. Body- mass index and mortality in Korean men and women. N Engl J Med 2006;355:779–7
Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763–78
Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 2006;295:190–8
Sjöström LV. Mortality of severely obese subjects. Am J Clin Nutr 1992;55(Suppl 5):16S–23S
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37
Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416–23
Johnston D, Dachtler J, Sue-Ling HM, et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg 2003;13:10–6
Carmichael AR, Sue-Ling HM, Johnston D. Quality of life after the Magenstrasse and Mill procedure for morbid obesity. Obes Surg 2001;11:708–15
Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003;13:861–4
Tzioni Yehoshua R, Eidelman AL, Stein M, et al. Laparoscopic sleeve gastrectomy-volume and pressure assessment. Obes Surg 2008;18:1083–8
Horvath TL, Diano S, Sotonyi P, et al. Ghrelin and the regulation of energy balance: a hypothalamic perspective. Endocrinology 2001;142:4163–9
Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002;56:203–6
Nakazato M, Murakami N, Isobe T, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194–8
Pardina E, Lopez-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg 2009;19:1414–23
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623–30
Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024–9
Langer FB, Bohdjalian A, Shakeri-Manesch S, et al. Eating behavior in laparoscopic sleeve gastrectomy – correlation between plasma gherlin levels and hunger. Eur Surg 2008;40:1–5
Lin E, Gletsu N, Fugate K, et al. Ghrelin levels in the morbidly obese. Arch Surg 2004;139:780–4
Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006:444:854–9
Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metabolism 2006:4:223–33
Beglinger C, Degen L. Gastrointestinal satiety signals in humans-physiologic roles for GLP-1 and PYY? Physiol Behav 2007:89:460–4
Hagan MM. Peptide YY: a key mediator of orexigenic behavior. Peptides 2002:23:377–82
Li F, Zhang G, Liang J, et al. Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg 2009;13:2302–8
Wynne K, Stanley S, Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 2004;89:2576–82
Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365:1597–604
Lautenbach A, Breitmeier D, Kuhlmann S, et al. Human obesity reduces the number of hepatic leptin receptor (ob-R) expressing NK cells. Endocr Res 2011;36:158–66
Tam CS, Lecoultre V, Ravussin E. Novel strategy for the use of leptin for obesity therapy. Expert Opin Biol Ther 2011;11(12):1677–85
Runkel N, et al. S3 Leitlinie Chirurgie der Adipositas. Chirurgische Allgemeine Zeitung 2010;11(11/12):615–22
Schauer P, Hamad G, Ikramuddin S. Surgical management of gastroesophageal reflux disease in obese patients. Semin Laparosc Surg 2001;8:256–64
Perry Y, Courcoulas AP, Fernando HC, et al. Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients. JSLS 2004;8:19–23
Merrouche M, Sabaté JM, Jouet P, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg 2007;17:894–900
Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006;16:1450–6
Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 2005;15:1469–75
Lazoura O, et al. Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology. Obes Surg 2011;21(3):295–9
Keidar A, Appelbaum L, Schweiger C, et al. Dilated upper sleeve can be associated with severe postoperative gastroesophageal dysmotility and reflux. Obes Surg 2010;20:140–7
Langer FB, Bohdjalian A, Felberbauer FX, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity. Obes Surg 2006;16:166–71
Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy – influence of sleeve size and resected gastric volume. Obes Surg 2007;17:1297–305
D'Hondt M, Vanneste S, Pottel H, et al. Laparoscopic sleeve gastrectomy as a single stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance and 6-year weight loss. Surg Endosc 2001;25:2498–504
Freire RH, Borges MC, Alvarez-Leite JI, et al. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition 2012;28(1):53–8
Author information
Authors and Affiliations
Corresponding author
Additional information
*: A tribute to Wolfgang Wayand, Head of Department, 1 January 1985–31 March 2012, Department of Surgery II, General Hospital Linz, Linz, Austria
Rights and permissions
About this article
Cite this article
Abrahim, A., Sperker, C., Kees-Belyus, M. et al. Technique and results of single-step laparoscopic sleeve resection* . Eur Surg 44, 23–27 (2012). https://doi.org/10.1007/s10353-011-0069-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10353-011-0069-0